Clinical Outcomes After Total Pancreatectomy: A Prospective Multicenter Pan-European Snapshot Study
- PMID: 33177356
- DOI: 10.1097/SLA.0000000000004551
Clinical Outcomes After Total Pancreatectomy: A Prospective Multicenter Pan-European Snapshot Study
Abstract
Objective: To assess outcomes among patients undergoing total pancreatectomy (TP) including predictors for complications and in-hospital mortality.
Background: Current studies on TP mostly originate from high-volume centers and span long time periods and therefore may not reflect daily practice.
Methods: This prospective pan-European snapshot study included patients who underwent elective (primary or completion) TP in 43 centers in 16 European countries (June 2018-June 2019). Subgroup analysis included cutoff values for annual volume of pancreatoduodenectomies (<60 vs ≥60).Predictors for major complications and in-hospital mortality were assessed in multivariable logistic regression.
Results: In total, 277 patients underwent TP, mostly for malignant disease (73%). Major postoperative complications occurred in 70 patients (25%). Median hospital stay was 12 days (IQR 9-18) and 40 patients were readmitted (15%). In-hospital mortality was 5% and 90-day mortality 8%. In the subgroup analysis, in-hospital mortality was lower in patients operated in centers with ≥60 pancreatoduodenectomies compared <60 (4% vs 10%, P = 0.046). In multivariable analysis, annual volume <60 pancreatoduodenectomies (OR 3.78, 95% CI 1.18-12.16, P = 0.026), age (OR 1.07, 95% CI 1.01-1.14, P = 0.046), and estimated blood loss ≥2L (OR 11.89, 95% CI 2.64-53.61, P = 0.001) were associated with in-hospital mortality. ASA ≥3 (OR 2.87, 95% CI 1.56-5.26, P = 0.001) and estimated blood loss ≥2L (OR 3.52, 95% CI 1.25-9.90, P = 0.017) were associated with major complications.
Conclusion: This pan-European prospective snapshot study found a 5% inhospital mortality after TP. The identified predictors for mortality, including low-volume centers, age, and increased blood loss, may be used to improve outcomes.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Griffin JF, Poruk KE, Wolfgang CL. Is it time to expand the role of total pancreatectomy for IPMN? Dig Surg. 2016;33:335–342.
-
- The European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.
-
- Andren-Sandberg A, Ansorge C, Yadav TD. Are there indications for total pancreatectomy in 2016? Dig Surg. 2016;33:329–334.
-
- Scholten L, Latenstein AE, van Eijck CH, et al. Outcome including long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study. Surgery. 2019;166:1017–1026.
-
- Scholten L, Stoop TF, Del Chiaro M, et al. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2019;106:1735–1746.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources